Algeria: Sanofi, the Africa largest industrial site

The ceremony to mark the beginning of Sanofi’s ambitious project of constructing its largest industrial site in Africa was well attended by Algerian authorities. The occasion was also used an opportunity to reiterate on the cooperation between them and renew their dedication towards contributing in the upgrading of the health sector with the signing of a letter of intent.
Chief Executive Officer Christopher A. Viehbacher of the firm said they will be investing almost 70 million euros on the Sidi Abdellah industrial site which covers an area of 6,6 hectares. He described the project as a sign of their commitment to the country for more than two decades. Upon completion, the site will be housing pharmaceutical and biotechnical laboratories and create 133 skilled job opportunities.
After the signing of the letter of intent, the Minister for Industrial Development and Investment Promotion, Amara Benyouness, and Minister Abdelmalek Boudiaf for Health, Population and Hospital Reform hoped that their collaboration with the firm will benefit the Algerians with regards to their health issues.
Sanofi focuses more on diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Nevertheless, it will be providing solutions for public prevention, screening and education especially in fighting against cardiovascular diseases diabetes, and hyperlipidemia before the end of the year. Health professionals will also benefit from their training during the program.
Sanofi is an integrated global healthcare leader which discovers, develops and distributes therapeutic solutions focused on patients’ needs. It already has 2 manufacturing sites in Algeria. The Sidi Abdellah industrial site, its largest in Africa, should be completed in the 3years. It will be producing both dry and liquid pharmaceutical forms with a production and distribution capacity of 100 million units per annum.